Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RACE: Rapid Dose Escalation of Quetiapine in Acute Schizophrenia
NCT00254787Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quetiapine in schizophrenia, sponsored by AstraZeneca. Started Jun 2005; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00254787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254787.